Tag Page CancerCare

Cancer Breakthrough: One-and-Done Treatment?

Big news for anyone following cancer treatments: the FDA just approved Breyanzi, a one-time cell therapy for adults with tough-to-treat marginal zone lymphoma. Instead of endless rounds of chemo, some patients could get a single infusion and see lasting results. This is a game-changer for those who’ve run out of options, and it could mean less time in the hospital and more time living life. The takeaway? Keep an eye on these new therapies—they’re changing the way we think about cancer care. #Business #Industry #CancerCare